US Patent Issued to Trellis Bioscience on June 2 for "Therapeutic protein formulations comprising anti-DNABII antibodies and uses thereof" (California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,941, issued on June 2, was assigned to Trellis Bioscience Inc. (Redwood City, Calif.).

"Therapeutic protein formulations comprising anti-DNABII antibodies and uses thereof" was invented by Lawrence M. Kauvar (San Francisco) and Stefan Ryser (Menlo Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to an aqueous therapeutic protein formulation including: (i) one or more therapeutic proteins, wherein the one or more therapeutic proteins include one or more anti-DNABII antibodies or antigen-binding fragments thereof in an amount ranging from 10 to 150 mg/mL; (ii) histidine buffer, (iii) NaCl, and (iv) an aqueo...